Decrease in uric acid in acute ischemic stroke correlates with stroke severity, evolution and outcome

Clinical Chemistry and Laboratory Medicine

Volumn 48, Issue 3, 2010, Pages 383-390

  Brouns, Raf ^a,b,c   Wauters, Annick ^b   Van De Vijver, Gerda ^c   De Surgeloose, Didier ^b   Sheorajpanday, Rishi ^b,c   De Deyn, Peter P ^b,c  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b MIDDELHEIM HOSPITAL   (Belgium)

^c UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Acute cerebral infarction; Stroke evolution; Stroke outcome; Stroke severity; Uric acid

Indexed keywords

URIC ACID;

AGED; ARTICLE; BRAIN INFARCTION SIZE; CEREBROVASCULAR ACCIDENT; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TRANSIENT ISCHEMIC ATTACK; URIC ACID BLOOD LEVEL;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; DISEASE PROGRESSION; FEMALE; HUMANS; KINETICS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; STROKE; TIME FACTORS; URIC ACID;

ANIMALIA;

EID: 77249165739     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2010.065     Document Type: Article

References (32)

1. Sies H. Oxidative stress: introductory remarks. In: Sies H, editor. Oxidative stress, London: Academic Press, 1985;1-8.
2. Brouns R, De Deyn PP. The complexity of neurobiochemical processes in acute ischemic stroke. Clin Neurol Neurosurg 2009;111:483-495
3. Becker BF. Towards the physiological function of uric acid. Free Radic Biol Med 1993;14:615-631
4. Squadrito GL, Cueto R, Splenser AE, Valavanidis A, Zhang H, Uppu RM, et al. Reaction of uric acid with peroxynitrite and implications for the mechanism of neuroprotection by uric acid. Arch Biochem Biophys 2000;376:333-337
5. Buettner GR. The pecking order of free radicals and antioxidants: lipid peroxidation, alpha-tocopherol, and ascorbate. Arch Biochem Biophys 1993;300:535-543
6. Yu ZF, Bruce-Keller AJ, Goodman Y, Mattson MP. Uric acid protects neurons against excitotoxic and metabolic insults in cell culture, and against focal ischemic brain injury in vivo. J Neurosci Res 1998;53:613-625
7. Romanos E, Planas AM, Amaro S, Chamorro A. Uric acid reduces brain damage and improves the benefits of rt-PA in a rat model of thromboembolic stroke. J Cereb Blood Flow Metab 2007;27:14-20.
8. Dimitroula HV, Hatzitolios AI, Karvounis HI. The role of uric acid in stroke: the issue remains unresolved. Neurologist 2008; 14:238-242
9. Weir CJ, Muir SW, Walters MR, Lees KR. Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke. Stroke 2003;34:1951-1956
10. Cherubini A, Polidori MC, Bregnocchi M, Pezzuto S, Cecchetti R, Ingegni T, et al. Antioxidant profile and early outcome in stroke patients. Stroke 2000;31:2295-2300
11. Karagiannis A, Mikhailidis DP, Tziomalos K, Sileli M, Savvatianos S, Kakafika A, et al. Serum uric acid as an independent predictor of early death after acute stroke. Circ J 2007;71: 1120-1127
12. Chamorro A, Obach V, Cervera A, Revilla M, Deulofeu R, Aponte JH. Prognostic significance of uric acid serum concentration in patients with acute ischemic stroke. Stroke 2002;33: 1048-1052
13. Leinonen JS, Ahonen JP, Lonnrot K, Jehkonen M, Dastidar P, Molnar G, et al. Low plasma antioxidant activity is associated with high lesion volume and neurological impairment in stroke. Stroke 2000;31:33-39
14. Waring WS, Convery A, Mishra V, Shenkin A, Webb DJ, Maxwell SR. Uric acid reduces exercise-induced oxidative stress in healthy adults. Clin Sci (Lond) 2003;105:425-430
15. Waring WS, Webb DJ, Maxwell SR. Systemic uric acid administration increases serum antioxidant capacity in healthy volunteers. J Cardiovasc Pharmacol 2001;38:365-371
16. Amaro S, Soy D, Obach V, Cervera A, Planas AM, Chamorro A. A pilot study of dual treatment with recombinant tissue plasminogen activator and uric acid in acute ischemic stroke. Stroke 2007;38:2173-2175
17. Amaro S, Planas AM, Chamorro A. Uric acid administration in patients with acute stroke: a novel approach to neuroprotection. Expert Rev Neurother 2008;8:259-270
18. Brouns R, Sheorajpanday R, Wauters A, De Surgeloose D, Marien P, De Deyn PP. Evaluation of lactate as a marker of metabolic stress and cause of secondary damage in acute ischemic stroke or TIA. Clin Chim Acta 2008;397:27-31.
19. Brouns R, Heylen E, Sheorajpanday R, Willemse JL, Kunnen J, De Surgeloose D, et al. Carboxypeptidase U (TAFIa) decreases the efficacy of thrombolytic therapy in ischemic stroke patients. Clin Neurol Neurosurg 2009;111:165-170
20. Brouns R, Sheorajpanday R, Kunnen J, De Surgeloose D, De Deyn PP. Clinical, biochemical and neuroimaging parameters after thrombolytic therapy predict long-term stroke outcome. Eur Neurol 2009;62:9-15.
21. Brouns R, Van Den Bossche J, De Surgeloose D, Sheorajpanday R, De Deyn PP. Clinical and biochemical diagnosis of small-vessel disease in acute ischemic stroke. J Neurol Sci 2009;285:185-90.
22. Brouns R, Marescau B, Possemiers I, Sheorajpanday R, De Deyn PP. Dimethylarginine levels in cerebrospinal fluid of hyperacute ischemic stroke patients are associated with stroke severity. Neurochem Res 2009;34:1642-1649
23. Birschel P, Ellul J, Barer D. Progressing stroke: towards an internationally agreed definition. Cerebrovasc Dis 2004;17: 242-252
24. Sulter G, Steen C, De Keyser J. Use of the Barthel index and modified Rankin scale in acute stroke trials. Stroke 1999;30: 1538-1541
25. Selim M, Savitz S, Linfante I, Caplan L, Schlaug G. Effect of pre-stroke use of ACE inhibitors on ischemic stroke severity. BMC Neurol 2005;5:10.
26. Gertler M, Garn S, Levine S. Serum uric acid in relation to age and physique in health and in coronary heart disease. Ann Intern Med 1951;34:1421-1431
27. Franse LV, Pahor M, Di BM, Shorr RI, Wan JY, Somes GW, et al. Serum uric acid, diuretic treatment and risk of cardiovascular events in the systolic hypertension in the elderly program (SHEP). J Hypertens 2000;18:1149-1154 (Pubitemid 30680326)
28. Lehto S, Niskanen L, Ronnemaa T, Laakso M. Serum uric acid is a strong predictor of stroke in patients with non-insulindependent diabetes mellitus. Stroke 1998;29:635-639
29. Gariballa SE, Hutchin TP, Sinclair AJ. Antioxidant capacity after acute ischaemic stroke. QJM 2002;95:685-690
30. Carty JL, Bevan R, Waller H, Mistry N, Cooke M, Lunec J, et al. The effects of vitamin C supplementation on protein oxidation in healthy volunteers. Biochem Biophys Res Commun 2000;273:729-735
31. Polidori MC, Stahl W, Eichler O, Niestroj I, Sies H. Profiles of antioxidants in human plasma. Free Radic Biol Med 2001;30:456-462
32. Britton M, Roden A. Progression of stroke after arrival at hospital. Stroke 1985;16:629-632